病人知道什么关于骨科生物学的? 感知到的有效性,安全性和影响治疗决定的因素
Jose Rafael Garcia1,2, Lucas V Pallone1, Ron Gilat1
1Department of Orthopaedics, Rush University Medical Center, Chicago, IL, USA.
Orthopaedic journal of sports medicine
|February 26, 2026
概括
患者对整形生物学药物的理解有限,对其有效性和安全性有很多误解. 改善医生沟通和患者教育对于关于这些再生疗法的知情决策至关重要.
科学领域:
- 整形外科手术 整形外科手术
- 再生医学是一种再生医学.
- 生物制剂 生物制剂 生物制剂
背景情况:
- 脊椎生物学研究正在扩大,但患者对疗效和安全性的理解缺乏.
- 营销宣称可能会误解再生疗法的真正潜力.
- 患者的理解有限,需要对感知和知识差距进行进一步的调查.
研究的目的:
- 评估患者对整形生物学药物的知识和看法.
- 为了识别有关脊椎生物学治疗的常见误解.
- 确定影响患者决策的信息的主要来源.
主要方法:
- 一项涉及骨科诊所357名患者的横截面研究.
- 问卷评估了患者的人口统计,态度,病史和信息来源.
- 使用统计分析,包括单变量比较,来评估数据.
主要成果:
- 只有44%的患者熟悉脊髓生理学药物,他们普遍认为疼痛/炎症管理和软骨修复.
- 富于血小板的血 (PRP) 是最被认可的脊椎生物学治疗方法.
- 患者的决策受到成本,外科医生的建议和副作用的担忧的影响,医生是主要的信息来源.
结论:
- 患者对整形生物学的熟悉和理解是有限的,这强调了需要加强患者教育的必要性.
- 医生在教育患者有关骨科生物学的方面发挥着至关重要的作用,解决疗效,安全性和财务影响.
- 关于成本和潜在副作用的明确沟通对于患者的知情同意和决策至关重要.
更多相关视频
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Factors Affecting Protein-Drug Binding: Patient-Related Factors
384
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
384
Drug Products: Biologics, Biosimilars and Interchangeables
311
Body:Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
311
Biopharmaceutical Factors Influencing Drug Product Design: Overview
382
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
382
Inflammatory Bowel Disease IV: Pharmacological Management
860
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
860
Biopharmaceutics and Pharmacokinetics: Overview
4.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.6K


